![](https://investorshub.advfn.com/uicon/564105.png?cb=1547105359)
Wednesday, May 01, 2019 6:54:52 AM
I've been working on a complex hematology analyzer for the past five years; initial regulatory approval was in 2016. Continued software development efforts were called Life Cycle Packages; a normal part of marketing and supporting such a device.
The software has to be complete enough to support full hardware functionality for Qualification, V&V, etc. but can and will still evolve after that.
Message in reply to:
Let me ask a simple question. What would be your thoughts if Medtronic or BioTronik announced a design freeze on a new pacemaker or defibrillator but the software was still evolving... most would realize that a device that is 90% software based in its function and safety features it’s not complete until the software is frozen.
I’ve been in this industry for almost 30 years and never seen an announcement or design freeze with a caveat. If it is standard that the software would evolve prior to launch then it wouldn’t be mentioned.
You can read it how you like but those are the facts. It may work out in the end but there’s a reason that was put in writing... in case their is a software delay.
BelizeMe
Cannabix Technologies and Omega Laboratories Inc. Provide Positive Developments on Marijuana Breathalyzer Testing • BLO • Jul 11, 2024 8:21 AM
ECGI Holdings Enhances Board with Artificial Intelligence (AI) Expert Ahead of Allon Apparel Launch • ECGI • Jul 10, 2024 8:30 AM
Avant Technologies to Meet Unmet Needs in AI Industry While Addressing Sustainability Concerns • AVAI • Jul 10, 2024 8:00 AM
Panther Minerals Inc. Launches Investor Connect AI Chatbot for Enhanced Investor Engagement and Lead Generation • PURR • Jul 9, 2024 9:00 AM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM